Literature DB >> 15017562

The impact of gross total resection on local control and survival in high-risk neuroblastoma.

Michael P La Quaglia1, Brian H Kushner, Wendy Su, Glenn Heller, Kim Kramer, Sara Abramson, Nancy Rosen, Suzanne Wolden, Nai-Kong V Cheung.   

Abstract

BACKGROUND/
PURPOSE: Gross total resection of the primary tumor in treatment of high-risk neuroblastoma remains controversial. Furthermore, there are few reports of the effect of primary tumor resection on local control as opposed to overall survival. The authors reviewed their institutional experience to assess the effect of primary tumor resection on local control and overall survival.
METHODS: A total of 141 patients were treated on protocol between November 1, 1979 and June 25, 2002 and are the subject of this report. Gross total resection was assessed by review of operative notes, postoperative computerized axial tomograms, and postoperative meta-iodobenzyl guanidine (MIBG)1 scans when available.
RESULTS: The median age was 3.3 years, and all patients were International Neuroblastoma Staging System (INSS) stage 4 with 79% having metastases to cortical bone. The primary site was the adrenal gland in 74%, the central abdominal compartment in 13%, the posterior mediastinum in 7%, and other sites in 6%. Gross total resection was accomplished in 103 (73%) but was more than 90% for the last 3 protocols. Five kidneys were lost overall. The probability of local progression was 50% in unresected patients compared with 10% in patients undergoing gross total resection (P <.01). Overall survival rate in resected patients was 50% compared with 11% in unresected patients (P <.01).
CONCLUSIONS: Our data indicate that local control and overall survival rate are correlated with gross total resection of the primary tumor in high-risk neuroblastoma. Gross total resection should be part of the management of stage 4 neuroblastoma in patients greater than 1 year of age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017562     DOI: 10.1016/j.jpedsurg.2003.11.028

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  36 in total

1.  Enhanced metastatic growth after local tumor resection in the presence of synchronous metastasis in a mouse allograft model of neuroblastoma.

Authors:  Maho Inoue; Yoshiki Tsuchiya; Nobuya Koike; Yasuhiro Umemura; Hitoshi Inokawa; Yuichi Togashi; Junnosuke Maniwa; Mayumi Higashi; Shigehisa Fumino; Tatsuro Tajiri; Kazuhiro Yagita
Journal:  Pediatr Surg Int       Date:  2019-09-25       Impact factor: 1.827

2.  A long-term follow-up of residual mass neuroblastoma in a patient with cystic fibrosis.

Authors:  Aldo Naselli; Federico Cresta; Federica Favilli; Rosaria Casciaro
Journal:  BMJ Case Rep       Date:  2015-01-05

3.  Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study.

Authors:  Rochelle Bagatell; Kieran McHugh; Arlene Naranjo; Collin Van Ryn; Chaim Kirby; Penelope Brock; Karen A Lyons; Lisa J States; Yesenia Rojas; Alexandra Miller; Sam L Volchenboum; Thorsten Simon; Barbara Krug; Sabine Sarnacki; Dominique Valteau-Couanet; Dietrich von Schweinitz; Birgit Kammer; Claudio Granata; Luca Pio; Julie R Park; Jed Nuchtern
Journal:  J Clin Oncol       Date:  2016-01-11       Impact factor: 44.544

4.  Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience.

Authors:  Jared R Robbins; Matthew J Krasin; Atmaram S Pai Panandiker; Amy Watkins; Jianrong Wu; Victor M Santana; Wayne L Furman; Andrew M Davidoff; Lisa M McGregor
Journal:  J Pediatr Surg       Date:  2010-04       Impact factor: 2.545

5.  Image-defined risk factors for nephrectomy in patients undergoing neuroblastoma resection.

Authors:  Irene Isabel P Lim; Debra A Goldman; Benjamin A Farber; Jennifer M Murphy; Sara J Abramson; Ellen Basu; Stephen Roberts; Michael P LaQuaglia; Anita P Price
Journal:  J Pediatr Surg       Date:  2016-03-02       Impact factor: 2.545

Review 6.  Neuroblastoma.

Authors:  Andrew M Davidoff
Journal:  Semin Pediatr Surg       Date:  2012-02       Impact factor: 2.754

7.  Radical Surgery Improves Survival in Patients with Stage 4 Neuroblastoma.

Authors:  Katherin Vollmer; Stefan Gfroerer; Till-Martin Theilen; Konrad Bochennek; Thomas Klingebiel; Udo Rolle; Henning Fiegel
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

8.  Surgical treatment of neuroblastoma: twenty-three years of experience at a single institution.

Authors:  A I Koivusalo; M P Pakarinen; R J Rintala; U M Saarinen-Pihkala
Journal:  Surg Today       Date:  2013-04-12       Impact factor: 2.549

9.  Neuroblastoma: treatment outcome after incomplete resection of primary tumors.

Authors:  Suk-Bae Moon; Kwi-Won Park; Sung-Eun Jung; Woong-Jae Youn
Journal:  Pediatr Surg Int       Date:  2009-07-21       Impact factor: 1.827

10.  High-dose chemotherapy and autologous stem cell rescue in patients with high-risk stage 3 neuroblastoma: 10-year experience at a single center.

Authors:  Jung Min Suh; Keon Hee Yoo; Ki Woong Sung; Ju Youn Kim; Eun Joo Cho; Hong Hoe Koo; Suk Koo Lee; Jhingook Kim; Do Hoon Lim; Yeon Lim Suh; Dae Won Kim
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.